近日,白云山发布2024年年报。披露公司去年营收减少0.69%至749.93亿元,归属净利润下滑30.09%至28.35亿元。分产品看,中成药收入60.66亿元,化学药收入36.9亿元。图片来源:企业公告截图从各产品库存量变化情况看,滋肾育胎丸库存量同比上升的原因是:该产品本年内加强了市场推广和产品营销力度,产销量齐升,下属生产企业预期未来市场需求增加,提前备好库存,致使库存量同比增加。夏桑菊颗粒...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.